DxLab Inc.

Private

Somerville, MassachusettsHealthcare & Life Scienceshttps://dxlab.bio/

Last Round

Accelerator

Sep 23, 2024

Total Funding Raised

$5.25M

Company Overview

DxLab Inc. is a biotechnology company that develops and commercializes point-of-care diagnostic solutions for rapid, on-site detection of dangerous pathogens.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Biotechnology, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Non-AI

Keywords

point-of-care testingPOC testingmolecular diagnosticsinfectious disease diagnosticsrapid diagnosticsportable testing systemsample-to-answerrazor and blade modelLAMP technologydiagnostic reagentsassay developmentpublic health surveillanceemergency use authorizationEUA

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DxLab Inc. Comps

Public and private peers based on sector, stage, and business model.

DxLab Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DxLab Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Sep 23, 2024
Grant	Jun 7, 2024
Seed	Dec 23, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Hojun Suk

Co-Founder & CEO

Founding Team

DxLab Inc. Investors

Notable investors and investment history

DxLab Inc. investors
Investor	Rounds
Neoteny	Seed
Greentown Labs	Seed
Ambrosia Investments	Seed
Unlock Capital	Accelerator
The E14 Fund	Seed
AFVentures	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 30, 2026
Monthly visitors grew 91% MoM, reaching 2K.
Nov 7, 2025
Monthly visitors increased 246% MoM, from 306 to 1.1K.

View all signals

DxLab Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

DxLab Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DxLab Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSomerville, Massachusetts

Employee Range2

Year Founded2020

Last FundingSep 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.